Evelia Apolinar-Jiménez

Evelia Apolinar-Jiménez

Auto-generated profile, based on publicly available information

Evelia Apolinar-Jiménez

Departamento de Investigación, Hospital Regional de Alta Especialidad del Bajío adscrito a Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-Bienestar), León, Mexico

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2014 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
Edel Rafael Rodea-MonteroEdel Rafael Rodea-Montero
Edel Rafael Rodea-Montero
MEMaría Lola Evia-Viscarra
María Lola Evia-Viscarra
EAEvelia Apolinar-Jiménez
Evelia Apolinar-Jiménez
Objective. To identify the degree of association between anthropometric indices and components of metabolic syndrome (MS) and to determine optimal cut-off points of these indices for predicting MS in obese adolescents.Methods. A cross-sectional study with a sample of (n=110) Mexican obese adolescents grouped by sex and the presence/absence of MS. BMI percentile, waist circumference (WC), and waist-to-height ratio (WHtR) were tested. ROC curves of the anthropometric indices were created to identify whether an index was a significant predictor of MS.Results. BMI percentile, WC, and WHtR were significantly correlated with systolic and diastolic blood pressure. As predictors of MS overall patients, the BMI percentile generated an area under curve (AUC) of 0.651 (P=0.008), cut-off point above the 99th percentile. WC generated an AUC of 0.704 (P<0.001), cut-off point of ≥90 cm. WHtR demonstrated an AUC of 0.652 (P=0.008), cut-off point of 0.60. WHtR ≥0.62 and WHtR ≥0.61 generate AUC of 0.737 (P=0.006) and AUC of 0.717 (P=0.014) for predicting hypertension and insulin resistance, respectively, in females.Conclusion. WHtR is a better tool than WC and BMI for identifying cardiometabolic risk. The overall criterion (WHtR ≥ 0.6) could be appropriate for predicting MS in obese Mexican adolescents.

1 January 2012 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
MEMaria Lola Evia-Viscarra
Maria Lola Evia-Viscarra
Edel Rafael Rodea-MonteroEdel Rafael Rodea-Montero
Edel Rafael Rodea-Montero
EAEvelia Apolinar-Jiménez
Evelia Apolinar-Jiménez
NMNathalie Muñoz-Noriega
Nathalie Muñoz-Noriega
LGLeticia Margarita García-Morales
Leticia Margarita García-Morales
JRJuan Gerardo Reyes-García
Juan Gerardo Reyes-García
To compare serum concentrations of inflammatory cytokines, interleukin 6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), adiponectin, and tumor necrosis factor alpha (TNFalpha), before and after 3 months treatment with metformin in obese adolescents with insulin resistance (IR). This was a randomized, double-blinded, clinical trial of two groups of obese adolescents with IR, aged 9-18 years: a placebo group (n=14) and a metformin group (n=12) who received 500 mg metformin every 12 h for 3 months. Anthropometric and biochemical (metabolic and inflammatory cytokines) assessments were compared at the beginning and end of treatment. After 3 months of treatment, body mass index (kg/m2) was reduced in both groups: placebo group (32.82 +/- 6.37-32.10 +/- 6.52; p=0.011) and metformin group (33.44 +/- 5.82-32.71 +/- 5.77; p=0.015). Serum fasting insulin concentrations (pmol/L) increased in the placebo group (189.45 +/- 112.64-266.06 +/- 167.79; p=0.01) and showed a slight decrease in the metformin group (256.82 +/- 113.89-229.25 +/- 86.53; p=0.64). Adiponectin concentrations (microg/mL) decreased in the placebo group (13.17 +/- 7.31-5.65 +/- 6.69; p=0.02), while these remained stable in the metformin group (8.57 +/- 3.98-7.86 +/- 6.23; p=0.64). In the metformin group, significant reductions were found in the variances of serum TNFalpha concentrations (p=0.006; Levene test). These results suggest that treating obese adolescents with IR using metformin for 3 months is an option for patients without response to traditional lifestyle change because metformin improves inflammatory activity, which is an etiological factor in cardiovascular disease development.

1 December 2013 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
MEMaria Lola Evia-Viscarra
Maria Lola Evia-Viscarra
Edel Rafael Rodea-MonteroEdel Rafael Rodea-Montero
Edel Rafael Rodea-Montero
EAEvelia Apolinar-Jiménez
Evelia Apolinar-Jiménez
SQSilvia Quintana-Vargas
Silvia Quintana-Vargas
The aim of this study was to estimate the prevalence of metabolic syndrome (MS) and its components in obese Mexican adolescents and to compare the clinical, anthropometric, and biochemical characteristics between patients with and without MS by sex. We conducted a cross-sectional study with a sample of 110 obese adolescents (boys and girls) from 8 to 16 years old (BMI ≥95th percentile), who were recruited in the pediatric obesity clinic of a third-level care hospital. A frequency analysis was used to estimate the prevalence of MS and its components, and the assessments were compared between the sexes and between the groups with and without MS using the Kruskal–Wallis test. The prevalence of MS was 62%. In order of prevalence, the following components of MS were observed in the sample: abdominal obesity (88%), high triglycerides (TG) (85%), low HDL-C (60%), hypertension (35%), and hyperglycemia (5%). In the groups with MS, hypertension (P<0.001), waist circumference (P=0.003), and TG (P=0.012) were significantly higher, and HDL-C (P<0.001) was significantly lower. In conclusion the prevalence of MS and its components is high among obese Mexican-Hispanic children. These findings show the importance of preventing and treating obesity in the early stages of life in order to decrease the incidence rates of cardiovascular disease and type 2 diabetes mellitus.

8 February 2025 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
Fanny Petermann-RochaFanny Petermann-Rocha
Fanny Petermann-Rocha
EAEvelia Apolinar-Jiménez
Evelia Apolinar-Jiménez
GFGerson Luis de Moraes Ferrari
Gerson Luis de Moraes Ferrari
CMCatalina Medina
Catalina Medina
GOGary O'Donovan
Gary O'Donovan

26 October 2025 in Obesity Reviews
Verified
Journal Article
Open access
AMAna Munguía
Ana Munguía
YAYatziri Ayvar‐Gama
Yatziri Ayvar‐Gama
Vania Lara-MejíaVania Lara-Mejía
Vania Lara-Mejía
RDRegina Durán
Regina Durán
CNClaudia Nieto
Claudia Nieto
SBSimón Barquera
Simón Barquera
Introduction: Mexico faces a public health crisis due to the rising prevalence of obesity and noncommunicable diseases, primarily driven by unhealthy food environments. Objective: To conduct a second implementation of the Food Environment Policy Index in Mexico to assess policy implementation levels related to healthy food environments and to compare progress made from 2016 to 2024. Methods: A national panel of 75 experts from three groups—64.0% from academia, 17.3% from government, and 18.7% from civil society organizations—assessed the level of policy implementation of 72 food environment‐related indicators against international best practices. Results: The highest levels of policy implementation were found in the Food Labeling domain (e.g., List of ingredients/nutrient declarations and Front‐of‐package labeling ) and the Monitoring and Intelligence domain (e.g., National surveys used in policy design and modification ). Eighteen indicators improved in 2024; differences in proportions were statistically significant. The Food Retail domain showed the highest improvement (e.g., Incentives to increase the offer of healthy foods in stores ). The expert panel identified five priority indicators and made corresponding recommendations. Conclusion: Mexico has made progress in several aspects of the food environment; however, significant gaps in policy implementation remain and must be addressed to sustain momentum toward transforming the food system and improving nutrition and health for the entire population.

27 September 2024 in Clinics
Verified
Journal Article
Open access
MRMartha Jocelyne Piñon Ruiz
Martha Jocelyne Piñon Ruiz
MARIA-RAQUEL HUERTA-FRANCOMARIA-RAQUEL HUERTA-FRANCO
MARIA-RAQUEL HUERTA-FRANCO
FLFrancisco Miguel Vargas Luna
Francisco Miguel Vargas Luna
EAEvelia Apolinar-Jimenez
Evelia Apolinar-Jimenez
JEJoel Máximo Soel Encalada
Joel Máximo Soel Encalada
The clinical findings of patients with Chronic Kidney Disease (CKD), which is characterized by malnutrition, sedentary lifestyle, uremia, and catabolism associated with dialysis produce changes in Body Composition (BC), causing increased Fat Mass (FM), decreased in both Lean Mass (LM) and Body Mineral Density (BMD), even despite uremic reversal after a Kidney Transplant (KT); immunosuppressive medications alter BC, increasing the risk of loss of the kidney transplant and cardiovascular diseases. To demonstrate whether there are differences in BC between a group of patients with KT and a group of patients on Hemodialysis (HD), when comparing them with a control group without the disease. In the present observational study, with a comparative design; 125 patients were evaluated (46 with KT, 47 on HD, and 32 from the healthy control group). The BC was evaluated with the full-body Dual-Energy X-Ray Absorptiometry (DEXA) method. The mean age and standard deviation (X±SD) of the study subjects were: 28.89 ± 5.76, 27.39 ± 5.04, and 29.63 ± 6.34 years for the HD, KT, and control subjects, respectively. The HD patients presented a total FM of 14.98 ± 6.96 kg in comparison with 20.1 ± 6.5 kg for the control group (p = 0.007), and 19.06 ± 7.94 kg for the group with KT (p = 0.02). The total LM was lower in the KT patients in comparison with the control group (p = 0.023). The content and total BMD were lower in both groups of patients with KT and HD. Although a comprehensive improvement in BC was expected after kidney transplantation, the results are not close to "normal' values, when compared with those of healthy subjects of the same age.